Keytruda (pembrolizumab)

What is Keytruda (pembrolizumab)?

Pembrolizumab (trade name Keytruda) is a new class of cancer treatment drug manufactured by Merck and Co, and approved by the FDA (USA) in September 2014. Pembrolizumab is the first PD-1 blocking drug to receive approval in the USA ...

... More »

FAQs about Keytruda (pembrolizumab)

How much does pembrolizumab cost? The current estimates are that pembrolizumab will cost around $12,500 per month. Does Keytruda ...

... More »

Related Disease Topics

Disease articles related to Keytruda (pembrolizumab) include:

... More Diseases »

Related Articles

Note: This site is for informational purposes only and is not medical advice. See your doctor or other qualified medical professional for all your medical needs.